Literature DB >> 2170529

Priming of neutrophils by lipopolysaccharide for enhanced release of superoxide. Requirement for plasma but not for tumor necrosis factor-alpha.

Y Aida1, M J Pabst.   

Abstract

When human neutrophils are incubated with LPS, they become primed for enhanced release of O2- in response to stimulation by FMLP. We investigated two aspects of LPS priming: 1) whether priming depends on secretion of TNF-alpha by monocytes present in neutrophil preparations, and 2) whether plasma is required for priming. Using plasma-Percoll gradients, we isolated neutrophils that contained only 0.1% monocytes. At 37 degrees C, these neutrophils were significantly primed by LPS (100 ng/ml) within 30 min. In contrast, LPS-treated monocytes required 60 min to secrete significant neutrophil-priming activity, the major component of which was TNF-alpha. Further, antibody against TNF-alpha failed to inhibit priming of neutrophils by LPS at 15, 30, and 45 min, and inhibited only 15% at 60 min. The results suggested that TNF-alpha or other factors from monocytes were not essential for priming of neutrophils by LPS. Neutrophils that had been washed free of plasma by centrifugation through 50% Percoll responded only weakly to LPS with respect to priming for enhanced O2- release and increased expression of alkaline phosphatase activity on the cell surface. Priming of washed neutrophils could be restored by adding back plasma (0.1 to 1.0%). This effect of plasma was not blocked by heating the plasma to 56 degrees C but was blocked at 100 degrees C. LPS priming could be blocked by polymyxin B, even in the presence of plasma. Thus, priming required both LPS and plasma. Neutrophils incubated with LPS in the absence of plasma were not primed by subsequent addition of plasma, but were primed by addition of plasma and LPS. Culture supernatants from neutrophils incubated with 20 ng/ml LPS in the absence of plasma failed to prime fresh neutrophils, but supernatants from neutrophils incubated with LPS in the presence of 1% plasma were able to prime fresh neutrophils. These results implied that neutrophils inactivated LPS and that plasma protected LPS from inactivation. Nevertheless, such inactivated LPS retained the ability to gel Limulus lysate at 10 pg/ml, and the ability to prime monocytes at 100 pg/ml. Thus, plasma prevented a neutrophil-specific inactivation of LPS.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2170529

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  28 in total

1.  Neisseria gonorrhoeae porin modifies the oxidative burst of human professional phagocytes.

Authors:  D R Lorenzen; D Günther; J Pandit; T Rudel; E Brandt; T F Meyer
Journal:  Infect Immun       Date:  2000-11       Impact factor: 3.441

2.  Phagocytosis by lipopolysaccharide-primed human neutrophils is associated with increased extracellular release of reactive oxygen metabolites.

Authors:  P Follin; C Dahlgren
Journal:  Inflammation       Date:  1992-04       Impact factor: 4.092

3.  Are soluble factors relevant for polymorphonuclear leukocyte dysregulation in septicemia?

Authors:  C Wenisch; W Graninger
Journal:  Clin Diagn Lab Immunol       Date:  1995-03

4.  Cross-talk between IRAK-4 and the NADPH oxidase.

Authors:  Sandrine Pacquelet; Jennifer L Johnson; Beverly A Ellis; Agnieszka A Brzezinska; William S Lane; Daniela B Munafo; Sergio D Catz
Journal:  Biochem J       Date:  2007-05-01       Impact factor: 3.857

5.  C2-ceramide and C6-ceramide inhibited priming for enhanced release of superoxide in monocytes, but had no effect on the killing of leukaemic cells by monocytes.

Authors:  Y Nakabo; M J Pabst
Journal:  Immunology       Date:  1997-04       Impact factor: 7.397

6.  Role of p38 in the priming of human neutrophils by peritoneal dialysis effluent.

Authors:  I Daniels; J Fletcher; A P Haynes
Journal:  Clin Diagn Lab Immunol       Date:  1999-11

7.  Lipopolysaccharide priming of superoxide release by human neutrophils: role of membrane CD14 and serum LPS binding protein.

Authors:  L Shapira; C Champagne; B Gordon; S Amar; T E Van Dyke
Journal:  Inflammation       Date:  1995-06       Impact factor: 4.092

8.  Role of MyD88 in diminished tumor necrosis factor alpha production by newborn mononuclear cells in response to lipopolysaccharide.

Authors:  Sen Rong Yan; Gefei Qing; David M Byers; Andrew W Stadnyk; Walla Al-Hertani; Robert Bortolussi
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

9.  Role of toll-like receptors 2 and 4, and the receptor for advanced glycation end products in high-mobility group box 1-induced inflammation in vivo.

Authors:  Marieke A D van Zoelen; Huan Yang; Sandrine Florquin; Joost C M Meijers; Shizuo Akira; Bernd Arnold; Peter P Nawroth; Angelika Bierhaus; Kevin J Tracey; Tom van der Poll
Journal:  Shock       Date:  2009-03       Impact factor: 3.454

10.  A critical 'threshold' of beta 2-integrin engagement regulates augmentation of cytokine-mediated superoxide anion release.

Authors:  Trevor R Walker; Marie-Helene Ruchaud-Sparagano; Sarah R McMeekin; Ian Dransfield
Journal:  Br J Pharmacol       Date:  2004-03-08       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.